According to their website, “The FDA will closely monitor the effects of the current changes over the next few years in order to help ensure that blood safety is maintained. At the same time, the FDA will continue to work in this area and review its donor deferral policies to ensure they reflect the most up-to-date scientific knowledge. This process must be data-driven, so the timeframe for future changes is not something that can be predicted.”
Versiti’s research has been used to support modifying the MSM donor policy to make blood donation more accessible. However, the FDA regulates blood donation requirements at the federal level.
To help support changing these laws, please contact your state’s elected representatives.